TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History
Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, ALBERTA (July 9, 2018) – Translational Research In Oncology (TRIO) today announced a collaboration with Novartis…
Read more